Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Cannabis May Reduce Risk of Cancer Metastasis

India has many famous contributions in the medical field in this world and now the cancer surgeons of Tata Memorial Hospital in Parel may soon add one more thing to it. Recently, they approved a trial of an at-home technique of injecting an inexpensive drug into and around a tumor just before it is removed from surgery. This medicine is made from cannabis. Earlier tests showed that these injections reduced the rate of recurrence of solid tumors by one-third.

Related: Tilray® Supports New Clinical Trial Evaluating the Efficacy of Medical Cannabis in Disorders Caused by Breast Cancer Treatment

Top 5 CBD Oil Brands for 2022

According to a report in the Times of India, this research was presented at the meeting of the European Society for Medical Oncology held in Paris on 9 September. At present, more tests are going on or are about to start to prove this point indisputably. The idea is the brainchild of breast cancer surgeon Dr Rajendra Badve, who is the director of the entire Tata Memorial Centre. Tata Memorial Center now manages nine hospitals across the country. These tests are being done in 10 other hospitals across the country.

Since the promotion of this research, 3 major incidents have happened. Lidocaine is now a part of breast cancer surgery at least in Tata hospitals. Secondly, its trial has started on patients of oral cancer at Tata Memorial and Balco Center in Raipur. Third and most importantly, the use of cannabis has been allowed for cancer patients whose tumors are not easy to inject it into.

The idea of ​​using lidocaine made from cannabis has been around for a long time. Unfortunately, surgery to remove the cancer itself in some ways alters the environment around the cancer site and increases the risk of cancer recurrence or metastasis. Whereas the study proved that in some breast cancer patients, this injection reduced the chances of cancer cells moving to other parts of the body. Due to which the chances of getting cancer again decreased.

Cannabis May Reduce Risk of Cancer Metastasis


About Cannin: Your Cannabis Stocks Resource

78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021. 

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +34% Gains in 2022
  • +56% Gains in 2021
  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.